Go Pro

Precipio (PRPO) Competitors

Precipio logo
$22.77 +1.12 (+5.17%)
As of 11:57 AM Eastern
This is a fair market value price provided by Massive. Learn more.

PRPO vs. OWLT, SEER, KEQU, RPID, and OPXS

Should you buy Precipio stock or one of its competitors? MarketBeat compares Precipio with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Precipio include Owlet (OWLT), Seer (SEER), Kewaunee Scientific (KEQU), Rapid Micro Biosystems (RPID), and Optex Systems (OPXS).

How does Precipio compare to Owlet?

Owlet (NYSE:OWLT) and Precipio (NASDAQ:PRPO) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends.

72.6% of Owlet shares are held by institutional investors. Comparatively, 10.5% of Precipio shares are held by institutional investors. 36.2% of Owlet shares are held by insiders. Comparatively, 16.6% of Precipio shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Owlet has a beta of 1.84, meaning that its stock price is 84% more volatile than the broader market. Comparatively, Precipio has a beta of 1.3, meaning that its stock price is 30% more volatile than the broader market.

Precipio has a net margin of -3.57% compared to Owlet's net margin of -42.54%. Owlet's return on equity of 0.00% beat Precipio's return on equity.

Company Net Margins Return on Equity Return on Assets
Owlet-42.54% N/A -18.02%
Precipio -3.57%-6.73%-4.49%

In the previous week, Precipio had 1 more articles in the media than Owlet. MarketBeat recorded 3 mentions for Precipio and 2 mentions for Owlet. Owlet's average media sentiment score of 1.34 beat Precipio's score of 0.34 indicating that Owlet is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Owlet
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Precipio
0 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Owlet presently has a consensus target price of $15.00, suggesting a potential upside of 177.78%. Given Owlet's stronger consensus rating and higher possible upside, analysts clearly believe Owlet is more favorable than Precipio.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Owlet
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Precipio
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Precipio has lower revenue, but higher earnings than Owlet. Precipio is trading at a lower price-to-earnings ratio than Owlet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Owlet$107.06M1.47-$39.68M-$3.07N/A
Precipio$24.05M1.69-$360K-$0.47N/A

Summary

Owlet beats Precipio on 10 of the 16 factors compared between the two stocks.

How does Precipio compare to Seer?

Precipio (NASDAQ:PRPO) and Seer (NASDAQ:SEER) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, media sentiment, risk, earnings and profitability.

Precipio has higher revenue and earnings than Seer. Precipio is trading at a lower price-to-earnings ratio than Seer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Precipio$24.05M1.69-$360K-$0.47N/A
Seer$14.68M8.33-$73.60M-$1.24N/A

10.5% of Precipio shares are held by institutional investors. Comparatively, 75.2% of Seer shares are held by institutional investors. 16.6% of Precipio shares are held by company insiders. Comparatively, 11.3% of Seer shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Precipio has a net margin of -3.57% compared to Seer's net margin of -464.78%. Precipio's return on equity of -6.73% beat Seer's return on equity.

Company Net Margins Return on Equity Return on Assets
Precipio-3.57% -6.73% -4.49%
Seer -464.78%-26.58%-23.51%

Precipio has a beta of 1.3, indicating that its stock price is 30% more volatile than the broader market. Comparatively, Seer has a beta of 1.59, indicating that its stock price is 59% more volatile than the broader market.

In the previous week, Seer had 11 more articles in the media than Precipio. MarketBeat recorded 14 mentions for Seer and 3 mentions for Precipio. Seer's average media sentiment score of 0.39 beat Precipio's score of 0.34 indicating that Seer is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Precipio
0 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Seer
3 Very Positive mention(s)
0 Positive mention(s)
11 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Seer has a consensus price target of $4.00, indicating a potential upside of 79.78%. Given Seer's stronger consensus rating and higher possible upside, analysts plainly believe Seer is more favorable than Precipio.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Precipio
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Seer
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
3.00

Summary

Seer beats Precipio on 9 of the 16 factors compared between the two stocks.

How does Precipio compare to Kewaunee Scientific?

Precipio (NASDAQ:PRPO) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, valuation, profitability, risk, dividends, earnings and analyst recommendations.

Kewaunee Scientific has a net margin of 3.41% compared to Precipio's net margin of -3.57%. Kewaunee Scientific's return on equity of 14.10% beat Precipio's return on equity.

Company Net Margins Return on Equity Return on Assets
Precipio-3.57% -6.73% -4.49%
Kewaunee Scientific 3.41%14.10%5.55%

Precipio has a beta of 1.3, suggesting that its share price is 30% more volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.71, suggesting that its share price is 29% less volatile than the broader market.

10.5% of Precipio shares are owned by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are owned by institutional investors. 16.6% of Precipio shares are owned by insiders. Comparatively, 14.1% of Kewaunee Scientific shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Precipio
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Kewaunee Scientific has higher revenue and earnings than Precipio. Precipio is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Precipio$24.05M1.69-$360K-$0.47N/A
Kewaunee Scientific$282.00M0.39$9.62M$3.2211.94

In the previous week, Precipio had 3 more articles in the media than Kewaunee Scientific. MarketBeat recorded 3 mentions for Precipio and 0 mentions for Kewaunee Scientific. Precipio's average media sentiment score of 0.34 beat Kewaunee Scientific's score of 0.00 indicating that Precipio is being referred to more favorably in the media.

Company Overall Sentiment
Precipio Neutral
Kewaunee Scientific Neutral

Summary

Kewaunee Scientific beats Precipio on 9 of the 14 factors compared between the two stocks.

How does Precipio compare to Rapid Micro Biosystems?

Precipio (NASDAQ:PRPO) and Rapid Micro Biosystems (NASDAQ:RPID) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, media sentiment, institutional ownership and valuation.

10.5% of Precipio shares are owned by institutional investors. Comparatively, 52.6% of Rapid Micro Biosystems shares are owned by institutional investors. 16.6% of Precipio shares are owned by company insiders. Comparatively, 12.7% of Rapid Micro Biosystems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Rapid Micro Biosystems has a consensus price target of $6.00, indicating a potential upside of 177.14%. Given Rapid Micro Biosystems' stronger consensus rating and higher possible upside, analysts clearly believe Rapid Micro Biosystems is more favorable than Precipio.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Precipio
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Rapid Micro Biosystems
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

Precipio has a beta of 1.3, indicating that its share price is 30% more volatile than the broader market. Comparatively, Rapid Micro Biosystems has a beta of 1.44, indicating that its share price is 44% more volatile than the broader market.

Precipio has higher earnings, but lower revenue than Rapid Micro Biosystems. Precipio is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Precipio$24.05M1.69-$360K-$0.47N/A
Rapid Micro Biosystems$33.59M2.98-$47.12M-$1.12N/A

In the previous week, Precipio had 1 more articles in the media than Rapid Micro Biosystems. MarketBeat recorded 3 mentions for Precipio and 2 mentions for Rapid Micro Biosystems. Precipio's average media sentiment score of 0.34 beat Rapid Micro Biosystems' score of 0.00 indicating that Precipio is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Precipio
0 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Rapid Micro Biosystems
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Precipio has a net margin of -3.57% compared to Rapid Micro Biosystems' net margin of -145.81%. Precipio's return on equity of -6.73% beat Rapid Micro Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
Precipio-3.57% -6.73% -4.49%
Rapid Micro Biosystems -145.81%-131.52%-67.48%

Summary

Precipio and Rapid Micro Biosystems tied by winning 8 of the 16 factors compared between the two stocks.

How does Precipio compare to Optex Systems?

Optex Systems (NASDAQ:OPXS) and Precipio (NASDAQ:PRPO) are related small-cap companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, analyst recommendations, risk, media sentiment, earnings and dividends.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Optex Systems
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
3.00
Precipio
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Precipio had 3 more articles in the media than Optex Systems. MarketBeat recorded 3 mentions for Precipio and 0 mentions for Optex Systems. Precipio's average media sentiment score of 0.34 beat Optex Systems' score of 0.00 indicating that Precipio is being referred to more favorably in the news media.

Company Overall Sentiment
Optex Systems Neutral
Precipio Neutral

Optex Systems has higher revenue and earnings than Precipio. Precipio is trading at a lower price-to-earnings ratio than Optex Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Optex Systems$41.18M1.95$5.15M$0.5919.53
Precipio$24.05M1.69-$360K-$0.47N/A

Optex Systems has a net margin of 10.00% compared to Precipio's net margin of -3.57%. Optex Systems' return on equity of 19.33% beat Precipio's return on equity.

Company Net Margins Return on Equity Return on Assets
Optex Systems10.00% 19.33% 15.82%
Precipio -3.57%-6.73%-4.49%

Optex Systems has a beta of 0.47, suggesting that its stock price is 53% less volatile than the broader market. Comparatively, Precipio has a beta of 1.3, suggesting that its stock price is 30% more volatile than the broader market.

19.1% of Optex Systems shares are held by institutional investors. Comparatively, 10.5% of Precipio shares are held by institutional investors. 27.7% of Optex Systems shares are held by company insiders. Comparatively, 16.6% of Precipio shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Optex Systems beats Precipio on 12 of the 15 factors compared between the two stocks.

Get Precipio News Delivered to You Automatically

Sign up to receive the latest news and ratings for PRPO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PRPO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PRPO vs. The Competition

MetricPrecipioHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$40.97M$9.92B$6.79B$12.63B
Dividend YieldN/A2.52%2.59%10.03%
P/E Ratio-48.7025.56282.1425.05
Price / Sales1.695.48573.4380.07
Price / Cash27.2526.2428.6046.71
Price / Book2.745.2111.096.19
Net Income-$360K$311.05M$3.49B$347.61M
7 Day Performance-0.65%-0.45%0.42%0.74%
1 Month Performance-9.86%-1.16%-4.33%-3.72%
1 Year Performance60.08%26.54%63.09%20.27%

Precipio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PRPO
Precipio
0.6011 of 5 stars
$22.77
+5.2%
N/A+52.2%$40.97M$24.05MN/A60
OWLT
Owlet
2.5129 of 5 stars
$5.36
-3.2%
$15.00
+180.1%
-30.3%$155.64M$107.06MN/A106
SEER
Seer
3.1351 of 5 stars
$2.08
-1.2%
$4.00
+92.8%
+4.2%$114.09M$14.68MN/A160
KEQU
Kewaunee Scientific
1.006 of 5 stars
$37.28
+2.4%
N/A-34.8%$106.91M$282.00M11.581,231
RPID
Rapid Micro Biosystems
2.131 of 5 stars
$2.07
-1.5%
$6.00
+190.0%
-35.6%$95.34M$34.38MN/A200

Related Companies and Tools


This page (NASDAQ:PRPO) was last updated on 8/3/2026 by MarketBeat.com Staff.
From Our Partners